492 results match your criteria: "Cochin University Hospital[Affiliation]"
Mol Vis
November 2024
Centre de Recherche des Cordeliers, INSERM, Université Paris Cité, Sorbonne Université, Physiopathology of ocular diseases: Therapeutic innovations, Paris, France.
Purpose: To investigate systemic and ocular toll-like receptor (TLR)-4 expression and its association with oxidative stress markers in ocular rosacea (OR).
Methods: This prospective study included 40 patients with rosacea with ocular involvement and 20 healthy volunteers. Tear break-up time (TBUT), Schirmer test, meibomoscore, and ocular surface disease index (OSDI) scores were estimated for all participants.
Invest Ophthalmol Vis Sci
October 2024
Centre de Recherche des Cordeliers, Inserm UMRS1138, Université Paris Cité, Sorbonne Université, Paris, France.
Purpose: Overactivation of the mineralocorticoid receptor (MR) pathway is proinflammatory and contributes to the pathogenesis of diabetic retinopathy and of age-related macular degeneration. Excess of aldosterone, the specific MR ligand, is known to stimulate the production of proinflammatory cytokines and chemokines in extrarenal tissues and cells. In the RPE/choroid complex, aldosterone upregulated genes encoding proteins of the inflammatory response and downregulated genes encoding proteins involved in synaptic activity and neurotransmitters.
View Article and Find Full Text PDFClin Exp Rheumatol
November 2024
Department of Rheumatology, CHU and University of Montpellier, Phymedexp, Université de Montpellier, INSERM, CNRS, Montpellier, France.
BMJ Open
October 2024
INSERM 1083, UMR CNRS 6015, MITOVASC, Equipe CarME, SFR ICAT, University of Angers, Angers, France.
Eur J Cancer
November 2024
University of Lorraine, Department of Hepato-Gastroenterology and digestive oncology, Nancy University Hospital, Nancy, France. Electronic address:
Background: Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis. The POLO trial showed that olaparib (PARP inhibitor) improved progression-free survival (PFS) but not overall survival (OS), when used as maintenance therapy after ≥ 16 weeks of disease control with first-line platinum-based chemotherapy in patients with germline (g) BRCA 1 or 2 pathogenic variants (PV) metastatic PDAC. However, real-world data on the effectiveness of olaparib are missing.
View Article and Find Full Text PDFJ Clin Invest
October 2024
Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France.
BioDrugs
November 2024
Jean Monnet Saint-Etienne University, Saint-Etienne University Hospital, Mines Saint-Etienne, INSERM, SAINBIOSE U1059, Saint-Etienne, France.
PLoS One
September 2024
Nantes Université, Nantes University Hospital, Intensive Care Unit, Motion-Interactions-Performance Laboratory (MIP), UR 4334, Nantes, France.
Clin Infect Dis
August 2024
Infectious Disease Department, Joseph Ducuing Hospital, Toulouse, France.
Blood Adv
October 2024
Department of Hematology, Centre Henri Becquerel, Rouen, France.
Tafasitamab plus lenalidomide (TAFA-LEN) treatment relevance pre- or post-anti-CD19 chimeric antigen receptor (CAR) T-cell therapy is debated. We analyzed patients with large B-cell lymphoma in the DESCAR-T registry treated with axi[1]cel or tisa-cel in ≥3rd line and TAFA-LEN before (n = 15, "TL-pre-CAR-T" set) or directly after (n = 52, "TL-post-CAR-T" set) CAR T-cell therapy. We compared TAFA-LEN v.
View Article and Find Full Text PDFInt J Gynaecol Obstet
January 2025
Department of Surgery, Americain Hopsital of Paris, Neuilly sur seine, France.
Endometriosis is a complex gynecologic disorder characterized primarily by symptoms of pelvic pain, infertility, and altered quality of life. National and international guidelines highlight the diagnostic difficulties and lack of conclusive diagnostic tools for endometriosis. Furthermore, guidelines are becoming questionable at an increasingly rapid rate as new diagnostic techniques emerge.
View Article and Find Full Text PDFEur Urol Oncol
August 2024
Oncology Department, Institut de Cancerologie Strasbourg Europe (ICANS), Strasbourg, France.
Therap Adv Gastroenterol
August 2024
Department of Gastroenterology, Nancy University Hospital, 1 Allée du Morvan, Vandoeuvre-lès-Nancy 54511, France.
A second autologous stem-cell transplantation (ASCT2) is considered for relapsed multiple myeloma (RMM) patients showing prolonged response after a first ASCT. However, given breakthrough treatments like anti-CD38 and immunotherapy, its role remains debated. We conducted a real-life study in 10 French centers (1996-2017) involving 267 RMM patients receiving ASCT2.
View Article and Find Full Text PDFTherapie
July 2024
Inserm U987, Paris Cité University, 92100 Boulogne-Billancourt, France; Pain Department, Cochin University Hospital, Assistance publique-Hôpitaux de Paris, 75014 Paris, France.
Am J Gastroenterol
July 2024
Department of Endoscopy and Gastroenterology, Dupuytren University Hospital, Limoges, France.
Introduction: The adoption of colorectal endoscopic submucosal dissection (ESD) is still limited in the West. A recent randomized trial showed that ESD is more effective and only slightly riskier than piecemeal endoscopic mucosal resection; reproducibility outside expert centers was questioned. We evaluated the results according to the annual case volume in a multicentric prospective cohort.
View Article and Find Full Text PDFCrit Care Explor
July 2024
Université de Paris, Inserm UMR-S 942 MASCOT, Paris, France.
J Fungi (Basel)
June 2024
Department of Medicine, Pneumology and Gastroenterology Units, Cayenne Hospital Center, Cayenne F-97300, French Guiana.
(1) Background: Only a few studies on histoplasmosis in immunocompetent patients have been reported in French Guiana. Therefore, we conducted a detailed clinical description of hospitalized patients suffering with histoplasmosis among non-HIV patients. (2) Methods: This is a single-center, retrospective study conducted at Cayenne Hospital Center between 2008 and 2022.
View Article and Find Full Text PDFSci Rep
June 2024
Center of Research in Myology, Institute of Myology, INSERM, Sorbonne University, 105, Boulevard de l'Hôpital, 75013, Paris, France.
Myasthenia gravis (MG) is an autoimmune disease characterized by muscle fatigability due to acetylcholine receptor (AChR) autoantibodies. To better characterize juvenile MG (JMG), we analyzed 85 pre- and 132 post-pubescent JMG (with a cutoff age of 13) compared to 721 adult MG patients under 40 years old using a French database. Clinical data, anti-AChR antibody titers, thymectomy, and thymic histology were analyzed.
View Article and Find Full Text PDFMed Educ Online
December 2024
Department of Emergency Medicine, Cochin University Hospital, APHP, Paris, France.
Eur J Clin Microbiol Infect Dis
August 2024
Infectious Diseases Department, Centre Hospitalier Annecy Genevois, Annecy, France.
Am J Hematol
August 2024
Department of Internal Medicine and Clinical Immunology, Aix Marseille Univ, APHM, La Timone Hospital, Marseille, France.
Clin Microbiol Infect
August 2024
Infectious Diseases Unit, Saint-Louis University Hospital, AP-HP, Paris, France.
Objectives: In this study, we aimed to assess the efficacy of different ways of administration and types of beta-lactams for hospitalized community-acquired pneumonia (CAP).
Methods: In this post-hoc analysis of randomized controlled trials (RCT) on patients hospitalized for CAP (pneumonia short treatment trial) comparing 3-day vs. 8-day durations of beta-lactams, which concluded to non-inferiority, we included patients who received either amoxicillin-clavulanate (AMC) or third-generation cephalosporin (3GC) regimens, and exclusively either intravenous or oral treatment for the first 3 days (followed by either 5 days of oral placebo or AMC according to randomization).
Respirology
August 2024
Pulmonology Department, Toulouse University Hospital, Toulouse, France.
Endoscopy
September 2024
Department of Gastroenterology, Hepatopancreatology and Digestive Oncology, CUB Erasme Hospital, HUB (Hôpital Universitaire de Bruxelles), Université Libres de Bruxelles (ULB), Brussels, Belgium.
Background: This study evaluated the safety and efficacy of salvage endoscopic submucosal dissection (ESD) for Barrett's neoplasia recurrence after radiofrequency ablation (RFA).
Methods: Data from patients at 16 centers were collected for a multicenter retrospective study. Patients who underwent at least one RFA treatment for Barrett's esophagus and thereafter underwent further esophageal ESD for neoplasia recurrence were included.